Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This one is SCAM, Blockchain used to in tandem with Cannabis to create hype. 10k shares nad 20k warrants ready to be sold in open mkt.
Good luck.
chk all the form 4's by insiders
May be all the insiders are going to sign a LOCK UP AGREEMENT.
Things will be clear by end of this week and from next week we start the journey to $2/-
Abattis has definitely got something Right this time around.
Partnership with Emerald for Northern Vine = Xlabs
Vergence Sales/Distribution
Extraction technology
1st and 3rd will be the one's they can focus and get most of their revenue out of it.
There alliance with emerald will help them penetrate other LP's requirements.
All LP's that are focused on expanding their capacity will soon shift their focus on "Extraction". CBD will be legalized across US soon.
Edibiles will be allowed in Canada by begining of 2019.
2018 will be significant year for Canadian LP's to partner and take advantage of Abattis Extraction technology.
In addition to these cost and scalability benefits, the technology can be used with both wet and dry products, which eliminates the need to dry cannabis products. Drying of the cannabis flower is not only expensive and time consuming, but could also lead to loss of terpenes and other active ingredients. The Raybot technology isolates only the desired active ingredients and removes all impurities, such as pesticides, without chemically altering the cannabinoids that are extracted, resulting in the purest formulations.
THCA and THCV have wider use than even CBD
http://info.pueblosbestmarijuana.com/blog/thc-thca-and-thcv-oh-my
Only Abattis has a industrial grade extractor that can separpate these components which 99% pure than any other in the industry.
Big Pharma are surely going to look at Abattis and not a small time extraction company.
Medicines requires commercial grade m/c's.
Shorters will get burnt.
Very good article, clearly shows Abattis technology is better than what's available with Radient.
Wait for someone as big as Aurora to partner with Abattis, infact Emerald might just do that soon
Had double botton, will go up
when you have more than 5 mil $ volum for two consecutive days and a strong base being built on the 2nd day, that means something bigger is in store and coming and folks don't want to be left behind for that run.
PREDICTION - OPENS AT 0.55
will be $1 by 11:30
then some pull back to $.85 and if it goes up, then it will close at $1.10
Everyone was after just CBD,
but Abattis has more to offer.
Check GW PHARMA uses THCA and THCV to treat Epilepsy
https://www.endoca.com/blog/discovery/thca-and-thcv-cannabinoids-of-the-future/
PHARMA IS GOING AFTER ABATTIS
https://www.google.com/patents/US20130059018
Cancer treatment requires all of these separated.
tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabigerol propyl variant (CBGV), tetrahydrocannabivarinic acid (THCVA), tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabigerol (CBG) and cannabichromene (CBC).
To develop drugs at the industrial grade once approved, guess whom they will partner with.
This technology is a GAME CHANGER.
Every LP will come to Abattis for Extraction.
It is industrial grade and most cost effective so far.
With the Edible market opening up soon and Abattis being able to separate each and every component of the plant, you are looking at Pharma's too coming to Abattis for getting medical grade, highly pure and organic raw material.
I think its all because mo one expected this kind of storm.
But ATTBF always had this wild streak in it if you look at the past history. It took less than a week to go from 10c to $2.58.
so based on history, it will most likely test the 2014 high's by end of this week or at the most next week.
How do you know that's not being in talks right now.
The ability to identify THC, CBD, THCA is a game changer.
With CBD soon to be removed off list and declared safer by WTO, Canada and may be US, all the edibles will want to extract it and infuse it per specific requirements. This one gives high yield at low cost.
All the LP's who are going to venture in CBD market will want to be ATTBF customer or Partner with it.
ATTBF can also use their Vergence Marketing to market these products.
This just begining and just as we can no longer get other LP's below $1 anymore, same will be the case of Abattis.
His extraction method and use of his key IP is currently one of the only toll-processing technologies that can extract high purity CBD on an industrial scale. We’re happy to have confirmed that it can fully separate individual compounds such as THCA.”
Looking back at 2014 pattern of ATTBF, this will open at 0.50's and will re-test 0.43's and go back up to test 0.75's
Looks like you missed the boat, get in before it goes to $2
ATTBF will most likely get bought out by Canopy or Emerald.
Aurora too is very aggressive and will go for bidding war
world's Best Extraction Technology
Vergence Sales/Products - Hemp Water, Drinks
XLabs - Testing/Partnership with Emerald
Extraction/Infusion services for Edibles
Looks like some of the LP's are going to work with ATTBF# to get get maximum yeild on their extraction.
Wait for new announcements that will follow in next two weeks
2018 ATTBF will test 2014 high - $2.78 will be tested - Mark this post, before July 2018, ATTBF will touch $2.78
Based on the write up one can only imagine the wide applications of LXRP's Lipid technology for delivery.
Nicotine/Tobacco industry $770b
CBD Infused edibles $50b (including Canada and US where applicable)
Pain medication - $800b
Merger with LP's.
The OS is just 70mil shares, even at $1.60 the mcap is just 100m.
Even if fraction of the above 3 industries revenue royalties go to LXRP, you can talk about $500m to $1b revenue in next 2 yrs if deals are made.
So that examples why the rush to get in now before it becomes a lot bigger and who know might even get listed to a better exchange than OTC.
This company has bought Patent and nothing else, they paid for creating website and power point and CEO is busy selling shares.
None of the form 4's are filed a mentioned in the filings on company website.
Completely agree, no one seem to be bothered by the form 4's that keep getting filed every other day.
Please use your time and effort to google it
The existing provisions are extended till Dec 15th based on the compromise on budge bill.
The Senate version already has approved the amendment. During consolidation, it will get attached to the bill by special committee.
check out POTUS is working with Nancy Pelosi and Chuck Schumaker.
Medical bill is definitely going to get approved.
The DACA lawsuits is a eye opener. More than 35 state's will file lawsuit against Jeff Session if Medical mj is not protected.
EVIO is a brand already in OR.
It is much bigger name and known than Signal Bay, so very likely a lot more investor's will be interested in investing in growth of EVIO.
The franchise is already looking to open in FL, MA and CA. Guaranteed to run after reverse split completes on Oct 3rd.
Something is wrong with this company
They have invested in everything and still not making revenues.
Not sure why none of the LP's have taken notice of Abattis even through they are in everything...
a> CBD / Hemp WAter
b> Biocube
c>Vitagum
d> Sun screen
e> Raybot's
f?Phythalabs
g>Nothervine CSL
h> Comfort, Soothe, etc.. NO2 formulations/drinks
Management is trying hard at everything, but haven't succeeded in anything except for Nothern vine CSL and Experion Partner ship. I hope they can monetize their NPN's on which they have spent quite sometime and resources.. Remember Brazo ...Phd guy and some other Master Extraction guy whom was on their payroll. None of that has worked so far.
Reno store is 1 out of 4 that City has approved, so it is getting more than 25% of the Mkt share. Other stores the ratio is 1:15, so there sales will never be like Reno. what can change is the elevation of branding. IVXX will help a lot once introduced in Blum stores
Meanwhile, that panel is expected to consider an amendment to continue blocking the U.S. Department of Justice from interfering with state medical cannabis laws on Thursday.
You missed the part on the last line of that news. Thursday vote will be game changer and layoff Session and his team from going after Medical marijuana
Lets see what ViPova tea does
http://norml.org/news/2017/06/15/study-cannabis-infused-tea-effective-for-treating-chronic-pain
the Debt has been paid off, using PP/options. If it was for Dutuchess, by now it would have gone back to 0.30's. It is holding up as it had support support above these level's
The lowest price of options left to be exercised is 0.68, so we are at the low end of it, I found two batches left, 0.68 and 0.75, so IMHO, the price should stabilize here and should go back to 0.90's in next month or so.
Do we know how many more users will get added once NV goes recreational...
https://www.wealthdaily.com/articles/is-it-time-to-invest-in-massroots-otcbb-msrt/8675
They have added new revenue streams and are trying to be the Big Data & Analytics provider in this space.
Outstanding at March 31, 2017 16,688,942 $ 0.75 9.14 $ 3,513,787
Exercisable at March 31, 2017 8,610,119 $ 0.68 8.89 $ 2,429,690
Buy on humor ,sell on News. This fluff PR news is out, expect it to go back and test 0.018s
Just imagine, when the company can return to profitability, they don't have to pay income taxes on the profits since there is loss carried over that they can claim. That will increase there Cash exponentially and allow them to buyout other dispensaries or locations
As of March 31, 2017 and December 31, 2016, the Company had net operating loss carryforwards of approximately $37,885,008 and $34,940,000, respectively, which, if unused, will expire beginning in the year 2034. These tax attributes are subject to an annual limitation from equity shifts, which constitute a change of ownership as defined under Internal Revenue Code (“IRC”) Section 382, which will limit their utilization. The Company has yet to assess the effect of these limitations, but expects these losses to be substantially limited. Accordingly, the Company has placed a reserve against any assets associated with these losses.
Looks like they allowed conversion and paid off approx. 500k in debt
Senior convertible promissory note dated December 16, 2016, issued to accredited investors, which matures June 16, 2018 and bears interest at a rate of 12% per annum. The conversion price is $0.27, subject to adjustment.
Mar 31 2017
$743,841
Dec 31 2016
$1,220,155
If Dana Rohrabacher goes to Supreme court against Trump, he is sure to win based on the past rulings. I am sure commonsense will prevail and tax dollars won't get wasted.
http://reason.com/blog/2017/05/08/trumps-medical-marijuana-threat-contradi
Last August the U.S. Court of Appeals for the 9th Circuit ruled that the Rohrabacher-Farr amendment prohibits the Justice Department from prosecuting medical marijuana suppliers who comply with state law, and the same analysis would also apply to civil forfeiture actions.
I am talking about 2014 when their OS was 48 mil, right now their OS is more than 570 mil, but their revenues too are 10 folds. I am comparing TRT# of 2014 with 4 mil in rev to GBLX of 2017 with 1-2 mil revenue.
GBLX has limited upside compared based on that comparison. This is OTC and you never know, but if you are speculating, IMHO, it has limited upside.